AbCellera Biologics Inc. has entered into a three-year partnership with Drs. Fabio Rossi and Michael Underhill of the University of British Columbia (UBC) to discover, test, and develop therapeutic antibodies for the treatment of Duchenne Muscular Dyst

https://business.financialpost.com/pmn/press-releases-pmn/business-wire-news-releases-pmn/fight-against-duchenne-muscular-dystrophy-gets-major-funding-boost#